Nuvalent Inc (NUVL)
69.25
-1.10
(-1.56%)
USD |
NASDAQ |
May 06, 16:00
69.25
0.00 (0.00%)
After-Hours: 20:00
Nuvalent Price to Book Value: 6.333 for May 6, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 03, 2024 | 6.434 |
| May 02, 2024 | 6.629 |
| May 01, 2024 | 6.461 |
| April 30, 2024 | 6.299 |
| April 29, 2024 | 6.214 |
| April 26, 2024 | 6.114 |
| April 25, 2024 | 6.042 |
| April 24, 2024 | 6.146 |
| April 23, 2024 | 6.182 |
| April 22, 2024 | 5.898 |
| April 19, 2024 | 5.740 |
| April 18, 2024 | 5.767 |
| April 17, 2024 | 5.876 |
| April 16, 2024 | 5.922 |
| April 15, 2024 | 5.97 |
| April 12, 2024 | 5.991 |
| April 11, 2024 | 6.219 |
| April 10, 2024 | 6.121 |
| April 09, 2024 | 6.402 |
| April 08, 2024 | 6.259 |
| April 05, 2024 | 6.420 |
| April 04, 2024 | 6.575 |
| April 03, 2024 | 6.767 |
| April 02, 2024 | 6.714 |
| April 01, 2024 | 7.05 |
| Date | Value |
|---|---|
| March 28, 2024 | 6.867 |
| March 27, 2024 | 7.009 |
| March 26, 2024 | 6.927 |
| March 25, 2024 | 6.991 |
| March 22, 2024 | 7.100 |
| March 21, 2024 | 7.274 |
| March 20, 2024 | 7.290 |
| March 19, 2024 | 7.141 |
| March 18, 2024 | 7.143 |
| March 15, 2024 | 7.389 |
| March 14, 2024 | 7.737 |
| March 13, 2024 | 8.085 |
| March 12, 2024 | 7.958 |
| March 11, 2024 | 7.649 |
| March 08, 2024 | 7.718 |
| March 07, 2024 | 7.633 |
| March 06, 2024 | 7.725 |
| March 05, 2024 | 7.446 |
| March 04, 2024 | 7.773 |
| March 01, 2024 | 7.972 |
| February 29, 2024 | 7.693 |
| February 28, 2024 | 7.806 |
| February 27, 2024 | 8.138 |
| February 26, 2024 | 7.921 |
| February 23, 2024 | 7.980 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
1.330
Minimum
May 16 2022
12.70
Maximum
Dec 15 2023
4.941
Average
4.077
Median
Oct 21 2022
Price to Book Value Benchmarks
| Geron Corp | 6.407 |
| Verastem Inc | 5.245 |
| Karyopharm Therapeutics Inc | -- |
| Syndax Pharmaceuticals Inc | 3.453 |
| AnaptysBio Inc | 7.828 |
Price to Book Value Related Metrics
| Price | 69.25 |
| Earnings Yield | -3.12% |
| Market Cap | 4.437B |